Nura Bio

Series-B+
nurabio.com Biotech & Healthcare South San Francisco, United States 11-50
Total Funding $141.8M
Latest Round $73.8M Series-B+
Last Announced Jun 22, 2026
Investors 4 Backers
Decision Makers 6 Verified

About Nura Bio

Developing neurotherapeutics to halt serious diseases before they progress too far

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters South San Francisco, United States
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website nurabio.com
Domain Registered Date Oct 10, 2019

Social & Network Presence

X / Twitter Profile @nurabio_ (58 followers) Created on Jul 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $73,800,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $68,000,000 · Series-A

    fundraisingfox.com

  3. Milestone

    X account created (@nurabio_)

    58 followers

  4. Milestone

    Website domain registered

    nurabio.com

Investors & Backers

4
Euclidean Capital
Samsara Biocapital
Sanofi Ventures
The Column Group

Funding History

2 Rounds
Series-B+ · Jun 22, 2026
Series-A · Sep 18, 2024

Founders & Leadership

4

Andrew Pieper

Founder

Work email & phone locked Unlock →

David Hewitt

Senior Vice President

Work email & phone locked Unlock →

MARC FREEMAN

Co-Founder

Work email & phone locked Unlock →

STEVE MCKNIGHT

Co-Founder

Previously / Related: Flare Therapeutics

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts